Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Weight Loss and Obesity Treatment In addition to their role in managing type 2 diabetes, GLP-1 agonists have gained significant attention for their potential in promoting weight loss and treating obesity
Participants maintaining the highest 12 mg dose of retatrutide lost an average of 30.3% of their body weight (38.5 kg) at 104 weeks, while those moving from the lowest 4 mg dose to the maximum tolerated dose lost an average of 27.9% of their body weight (33.2 kg)
On a GLP-1, the direction worth watching is a steep drop, which usually points back to not eating enough protein
Add the sterile diluent (bacteriostatic water at a typical 2 mL volume for cell-culture protocols, or sterile saline for vascular research assays) directly to the lyophilized vial under aseptic technique
This dual mechanism is significant because, as mentioned earlier, tirzepatide maintained anti-inflammatory effects even when neuronal GLP-1 receptors were knocked out in animal models
